Related Experiment Videos
Abstract:
Regulatory or structural alterations of cellular oncogenes have been implicated in the causation of various cancers. Oncogene alteration by point mutations can result in a protein product with strongly enhanced oncogenic potential. Aberrant expression of cellular oncogenes may be due to tumor-specific chromosomal translocations that dysregulate the normal functions of a proto-oncogene. Amplification of cellular oncogenes can also augment their expression by increasing the amount of DNA template available for the production of mRNA. It appears that amplification of certain oncogenes is a common correlate of the progression of some tumours and also occurs as a rare sporadic event affecting various oncogenes in different types of cancer. Amplified copies of oncogenes may or may not be associated with chromosomal abnormalities signifying DNA amplification: double minute chromosomes and homogeneously staining chromosomal regions. Amplified oncogenes, whether sporadic or tumour type-specific, are expressed at elevated levels, in some cases in cells where their diploid forms are normally silent. Increased dosage of an amplified oncogene may contribute to the multistep progression of at least some cancers.
Insights
Alterations in cellular oncogenes, through mutations or amplification, can drive cancer development. These genetic changes lead to increased oncogene expression, contributing to tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cellular oncogenes play critical roles in cell growth and differentiation.
- Dysregulation of oncogene activity is a hallmark of cancer causation.
- Various genetic alterations can lead to oncogene malfunction.
Purpose of the Study:
- To review the mechanisms by which cellular oncogene alterations contribute to cancer.
- To explore the impact of point mutations, chromosomal translocations, and gene amplification on oncogene function.
- To understand how altered oncogene expression drives tumor progression.
Main Methods:
- Literature review of studies on oncogene alterations in cancer.
- Analysis of genetic mechanisms including point mutations, chromosomal translocations, and gene amplification.
- Examination of the relationship between oncogene dosage and expression levels.
Main Results:
- Point mutations can create oncogenic proteins with enhanced activity.
- Chromosomal translocations can lead to aberrant proto-oncogene expression.
- Gene amplification increases oncogene copy number, augmenting mRNA and protein production.
- Amplified oncogenes are often expressed at high levels, even in normally silent cells.
Conclusions:
- Altered cellular oncogenes are key drivers in the development and progression of various cancers.
- Mechanisms like mutation, translocation, and amplification contribute to oncogenic potential.
- Increased oncogene dosage from amplification is a significant factor in multistep cancer progression.